Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott Medical Devices
With
Thoratec Europe Ltd
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
HeartMate II Left Ventricular Assist Device (LVAD) patient
Patient has signed an informed consent for data collection.
Patient was discharged, or is being discharged, from the hospital after their initial LVAD implant surgery.
Patient:
* at time of enrolling in study, is currently on, with the intention of being maintained on reduced anti-thrombotic therapy (RT) for chronic long-term management.
OR
\-- On or after January 1, 2011 patient was being maintained on, or had been initiated with the intention of being maintained on, reduced anti-thrombotic therapy (RT) for chronic long-term management; but where RT was subsequently discontinued due to an adverse event or transplant, explant, or death.
You may not be if
Patients under acute management of anti-thrombotic agents before a final decision on long term antithrombotic strategy.
Patients requiring a legal representative to sign consent form, rather than themselves.
Patient is being managed on other anti-thrombotic agents